2Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量：53
4Deng-Fu Yao,Xin-Hua Wu,Xiao-Qin Su,Min Yao, Wei Wu, Li-Wei Qiu, Li Zou and Xian-Yong Meng The Institute of Clinical Medicine, Nantong University, and Department of Gastroenterology,Affiliated Hospital of Nantong University, Nantong 226001, China,and Nanjing Medical University, Nanjing 210009, China.Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):381-386. 被引量：14
9Shaib YH, E1-Serag HB, Davila JA, et al. Risk factors of in- trahepatic cholangiocarcinoma in the United States a case- control study[J]. Gastroenterology, 2005,128 : 620-626.
10Shaib YH, Davila JA, Mcglynn K, ct al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? [J]. J Hepatol,2004,40:472-477.
